Glycyl-glutamine inhibits nicotine conditioned place preference and withdrawal.

Göktalay, Gökhan; Cavun, Sinan; Levendusky, Mark C; Hamilton, Jonathan R; Millington, William R

Göktalay, Gökhan; Cavun, Sinan; Levendusky, Mark C; Hamilton, Jonathan R; Millington, William R.

Affiliation

Göktalay G; Department of Basic and Pharmaceutical Sciences, Albany College of Pharmacy, Union University, NY 12208, USA.

Eur J Pharmacol ; 530(1-2): 95-102, 2006 Jan 13.

Article in En | MEDLINE | ID: mdl-16364288

Subject(s)

Conditioning, Psychological/drug effects; Dipeptides/pharmacology; Nicotine/pharmacology; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer/pharmacology; Animals; Avoidance Learning/drug effects; Dose-Response Relationship, Drug; Injections, Intraventricular; Injections, Subcutaneous; Male; Mecamylamine/pharmacology; Nicotinic Agonists/pharmacology; Nicotinic Antagonists/pharmacology; Peptides, Cyclic/pharmacology; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa/agonists; Substance Withdrawal Syndrome/prevention & control; Time Factors

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Conditioning, Psychological / Dipeptides / Nicotine Limits: Animals Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Conditioning, Psychological / Dipeptides / Nicotine Limits: Animals Language: En Year: 2006 Type: Article